FDA Inspection 1277747 — Eurofins Biopharma Product Testing Munich GmbH
The FDA completed an inspection of Eurofins Biopharma Product Testing Munich GmbH on June 23, 2023 in Planegg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 23, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Planegg (Germany)
Additional Details
Mutual Recognition Agreement (MRA)